Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density

Richard Eastell; Dennis M Black; Steven Boonen; Silvano Adami; Dieter Felsenberg; Kurt Lippuner; Steven R. Cummings; Pierre D. Delmas; Lisa Palermo; Peter Mesenbrink; Jane A. Cauley; Horizon Pivotal Fracture Trial; W. D. Fraser

doi:10.1210/jc.2008-2765

Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density

Richard Eastell, Dennis M Black, Steven Boonen, Silvano Adami, Dieter Felsenberg, Kurt Lippuner, Steven R. Cummings, Pierre D. Delmas, Lisa Palermo, Peter Mesenbrink, Jane A. Cauley, Horizon Pivotal Fracture Trial, W. D. Fraser

Research output: Contribution to journal › Article

106 Citations (Scopus)

Abstract

ZOL appeared more effective in preventing vertebral fracture in younger women, overweight/obese women, and women with normal renal function. ZOL had similar effects irrespective of fracture risk factors or femoral neck BMD.

Original language	English
Pages (from-to)	3215-3225
Number of pages	11
Journal	The Journal of Clinical Endocrinology and Metabolism
Volume	94
Issue number	9
DOIs	https://doi.org/10.1210/jc.2008-2765
Publication status	Published - Sept 2009

Access to Document

10.1210/jc.2008-2765

Cite this

Eastell, R., Black, D. M., Boonen, S., Adami, S., Felsenberg, D., Lippuner, K., Cummings, S. R., Delmas, P. D., Palermo, L., Mesenbrink, P., Cauley, J. A., Fracture Trial, H. P., & Fraser, W. D. (2009). Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density. The Journal of Clinical Endocrinology and Metabolism, 94(9), 3215-3225. https://doi.org/10.1210/jc.2008-2765

@article{1b414775c69c4e1aa85d99a21a0c8cda,

title = "Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density",

abstract = "ZOL appeared more effective in preventing vertebral fracture in younger women, overweight/obese women, and women with normal renal function. ZOL had similar effects irrespective of fracture risk factors or femoral neck BMD.",

author = "Richard Eastell and Black, {Dennis M} and Steven Boonen and Silvano Adami and Dieter Felsenberg and Kurt Lippuner and Cummings, {Steven R.} and Delmas, {Pierre D.} and Lisa Palermo and Peter Mesenbrink and Cauley, {Jane A.} and {Fracture Trial}, {Horizon Pivotal} and Fraser, {W. D.}",

year = "2009",

month = sep,

doi = "10.1210/jc.2008-2765",

language = "English",

volume = "94",

pages = "3215--3225",

journal = "The Journal of Clinical Endocrinology and Metabolism",

issn = "0021-972X",

publisher = "Oxford University Press",

number = "9",

}

Eastell, R, Black, DM, Boonen, S, Adami, S, Felsenberg, D, Lippuner, K, Cummings, SR, Delmas, PD, Palermo, L, Mesenbrink, P, Cauley, JA, Fracture Trial, HP & Fraser, WD 2009, 'Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density', The Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 9, pp. 3215-3225. https://doi.org/10.1210/jc.2008-2765

TY - JOUR

T1 - Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density

AU - Eastell, Richard

AU - Black, Dennis M

AU - Boonen, Steven

AU - Adami, Silvano

AU - Felsenberg, Dieter

AU - Lippuner, Kurt

AU - Cummings, Steven R.

AU - Delmas, Pierre D.

AU - Palermo, Lisa

AU - Mesenbrink, Peter

AU - Cauley, Jane A.

AU - Fracture Trial, Horizon Pivotal

AU - Fraser, W. D.

PY - 2009/9

Y1 - 2009/9

N2 - ZOL appeared more effective in preventing vertebral fracture in younger women, overweight/obese women, and women with normal renal function. ZOL had similar effects irrespective of fracture risk factors or femoral neck BMD.

AB - ZOL appeared more effective in preventing vertebral fracture in younger women, overweight/obese women, and women with normal renal function. ZOL had similar effects irrespective of fracture risk factors or femoral neck BMD.

U2 - 10.1210/jc.2008-2765

DO - 10.1210/jc.2008-2765

M3 - Article

SN - 0021-972X

VL - 94

SP - 3215

EP - 3225

JO - The Journal of Clinical Endocrinology and Metabolism

JF - The Journal of Clinical Endocrinology and Metabolism

IS - 9

ER -